Detail of the clinical trial
| Title of the trial | Phase III trial of combined immunochemotherapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) versus Bendamustine and Rituximab (BR) in patients with previously untreated chronic lymphocytic leukemia. |
|---|---|
| EudraCT number | 2007-007587-21 |
| Protocol number | 994 |
| Sponsor | GCLLSG-Dept.of Internal Medicine I, University Hospital Cologne, GERMANY |
| Indications | Hemato-oncology |
| Diagnosis | chronic lymphocytic leukemia |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2010 |
| Date of approval by Institute (SÚKL) | 14.10.2010 |
| Date of approval by EC | 1.10.2010 |
| Date of initiation CT in ČR | 28.3.2011 |
| Date of ending CT in ČR | 15.2.2018 |
| Notice | |
| Sites |
FN Hradec Králové, hematoonk.kl. (discontinued) VFN, I.interní klinika-hematologie FN Olomouc, hemato-onk.klinika FN Královské Vinohrady, odd.kl.hematologie (discontinued) FN Brno, Interní hemato-onk.kl. (discontinued) |
cz